Congress passed the Corporate Transparency Act (CTA) as an anti-money-laundering initiative in 2021. Absent an applicable exemption,[1] the CTA requires all entities formed or registered to do business in the US (reporting companies) to
Synthesis, Issue 1
The month in life sciences and intellectual property
Welcome to the inaugural issue of Synthesis, a regular publication offering our perspective on the latest developments in life sciences and intellectual property.
From the lab…
DOJ previews policy changes: Key takeaways
On March 7, 2024, Deputy Attorney General Lisa Monaco delivered keynote remarks at the American Bar Association’s 2024 National Institute on White Collar Crime, reiterating the key priorities set by the US Department of Justice…
Continue Reading DOJ previews policy changes: Key takeawaysDOJ announces proposed rule to mitigate data security risks related to AI
On February 28, 2024, President Joe Biden issued an Executive Order titled “Preventing Access to Americans’ Bulk Sensitive Personal Data and US Government-Related Data by Countries of Concern” (EO). This order seeks to restrict the…
New US sanctions target Russia and Russian sanctions evaders in financial, technology, defense, energy, and other sectors
On February 23, 2024, the US Treasury Department’s Office of Foreign Assets Control (OFAC), in conjunction with the US State Department, added over 500 entities and individuals to the Specially Designated Nationals and Blocked Persons…
Continue Reading New US sanctions target Russia and Russian sanctions evaders in financial, technology, defense, energy, and other sectorsTreasury proposes new anti-money laundering rule for investment advisers: Top points
On February 13, 2024, the US Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) announced a Notice of Proposed Rulemaking (NPRM). This would, for the first time, require SEC-Registered Investment Advisers (RIAs) and Exempt…
Continue Reading Treasury proposes new anti-money laundering rule for investment advisers: Top pointsFDA’s new Quality Management System Regulation is here: Key takeaways for device companies in US, EU, and China
On January 21, 2024, the FDA issued a final rule amending its Quality System (QS) regulations under 21 CFR Part 820, which addresses current good manufacturing practice (CGMP) requirements for medical device manufacturers. The amendments…
Continue Reading FDA’s new Quality Management System Regulation is here: Key takeaways for device companies in US, EU, and ChinaNew York’s High Court affirms attorney-client privilege for in-house training materials
New York’s highest court, the Court of Appeals, recently issued an opinion explaining and clarifying the scope of the attorney-client privilege under New York law. The opinion is a useful reminder to in-house counsel that…
Guest Blog: UK Supreme Court confirms inventor must be a real person, providing critical guidance on AI-generated inventions
Written by: Sarah Turner, Liam Blackford, Bridie Barton
On 20 December 2023, the UK Supreme Court handed down its long awaited judgment in Thaler v. Comptroller-General of Patents, Designs and Trademarks, dismissing Stephen…
Continue Reading Guest Blog: UK Supreme Court confirms inventor must be a real person, providing critical guidance on AI-generated inventionsGuest Blog: HHS finalizes significant changes to the ONC Health IT Certification Program focusing on AI transparency and interoperability
Written by: Keo Shaw, Danny Tobey, Kristi Kung, Bennett Borden, Ashley Carr
On December 13, 2023, the US Department of Health and Human Services (HHS), via the Office of the National Coordinator for Health Information…
Continue Reading Guest Blog: HHS finalizes significant changes to the ONC Health IT Certification Program focusing on AI transparency and interoperability